GI & Endoscopy

Seven gastroenterologists share insight into the best ideas for improving patient engagement in gastroenterology.

Medigus, a developer of minimally invasive endosurgical tools and direct visualization technology, has been listed and has begun trading American depository receipts on the NASDAQ Capital Market. Here are five things to know.

Ronald Vender, MD, FACG, is a professor of medicine and the associate dean for clinical affairs at Yale School of Medicine as well as CMO of Yale Medical Group in New Haven, Conn.

Synthetic Biologics, a company focused on microbiome research, presented two posters at Digestive Disease Week this year.

Here are seven recent news updates on gastroenterology and endoscopy companies.

Nathan Littauer Hospital in Gloversville, N.Y., has opened the Johnstown (N.Y.) Endoscopy and Surgery Center, according to a readMedia report. Here are three key points on the new center.

Biotechnology company ColonaryConcepts has enrolled its first patient in a phase 2 clinical trial of colon preparation. 

James Scolapio, MD, is the chief of the gastroenterology division and associate chair of the department of medicine at the University of Florida in Jacksonville.

Mauna Kea Technologies' Cellvizio technology has received a CE mark for use in minimally invasive laparoscopic surgical indications.

Research presented at Digestive Disease Week examined colonoscopy and endoscopy as delivery mechanisms for fecal microbiota transplantation, according to an HCPLive report.